Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Chattopadhyay K.

Indian J Hum Genet. 2011 Sep;17(3):132-44. doi: 10.4103/0971-6866.92087.

2.

Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.

Cox JT.

Baillieres Clin Obstet Gynaecol. 1995 Mar;9(1):1-37. Review.

PMID:
7600720
3.

Susceptibility to cervical cancer: an overview.

de Freitas AC, Gurgel AP, Chagas BS, Coimbra EC, do Amaral CM.

Gynecol Oncol. 2012 Aug;126(2):304-11. doi: 10.1016/j.ygyno.2012.03.047. Epub 2012 Apr 4. Review.

PMID:
22484226
4.

Human papillomavirus vaccination in adolescence.

Russell M, Raheja V, Jaiyesimi R.

Perspect Public Health. 2013 Nov;133(6):320-4. doi: 10.1177/1757913913499091. Epub 2013 Sep 4. Review.

PMID:
24006173
5.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
6.

Human papillomavirus infection and the risk of cervical cancer in Japan.

Matsumoto K, Yoshikawa H.

J Obstet Gynaecol Res. 2013 Jan;39(1):7-17. doi: 10.1111/j.1447-0756.2012.01977.x. Epub 2012 Aug 26. Review.

PMID:
22925027
8.

[Human papillomavirus and cervical cancer].

Matsumoto K.

Nihon Rinsho. 2007 Nov;65(11):2113-24. Review. Japanese.

PMID:
18018579
9.

Human papillomavirus vaccines: current status and future prospects.

Garland SM, Smith JS.

Drugs. 2010 Jun 18;70(9):1079-98. doi: 10.2165/10898580-000000000-00000. Review.

PMID:
20518577
12.

Global burden of human papillomavirus and related diseases.

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.

Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Review.

PMID:
23199955
13.
14.

Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix.

Syrjänen K.

Eur J Gynaecol Oncol. 2007;28(5):337-51. Review.

PMID:
17966211
15.

Human papillomavirus, cervical cancer, and the vaccines.

Tovar JM, Bazaldua OV, Vargas L, Reile E.

Postgrad Med. 2008 Jul;120(2):79-84. doi: 10.3810/pgm.2008.07.1794. Review.

PMID:
18654072
16.

Human papillomavirus infection and the primary and secondary prevention of cervical cancer.

Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M.

Cancer. 2008 Oct 1;113(7 Suppl):1980-93. doi: 10.1002/cncr.23704. Review.

18.

[Human papillomavirus and cervical neoplasia].

Rosa MI, Medeiros LR, Rosa DD, Bozzeti MC, Silva FR, Silva BR.

Cad Saude Publica. 2009 May;25(5):953-64. Review. Portuguese.

19.

[Epidemiology of cervical papillomavirus infections. Recent knowledge].

Mougin C, Dalstein V, Prétet JL, Gay C, Schaal JP, Riethmuller D.

Presse Med. 2001 Jun 9;30(20):1017-23. Review. French.

PMID:
11433694
20.

Immunity to oncogenic human papillomaviruses.

Konya J, Dillner J.

Adv Cancer Res. 2001;82:205-38. Review.

PMID:
11447764

Supplemental Content

Support Center